Regulatory and Reimbursement 2008

Medicare has tightened their rules regarding paying for drug wastage, and many other payors are doing the same.  For payors who have no written parameters on this issue, the causes of waste, Medicare policies regarding waste, and the impact of these two factors on community oncology practives and other outpatient sites of service will be reviewed.  Suggestion for payment polocies that may prove fair to all stakeholders are presented

view PDF